We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
Cap. Flow
-$3.2B
Cap. Flow %
-3.77%
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$128M
2
DHR icon
Danaher
DHR
+$114M
3
ZBRA icon
Zebra Technologies
ZBRA
+$112M
4
AIZ icon
Assurant
AIZ
+$92.7M
5
EXC icon
Exelon
EXC
+$92.2M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.17%
3 Financials 13.51%
4 Industrials 10.72%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARI
1401
Apollo Commercial Real Estate
ARI
$876M
$835K ﹤0.01%
77,600
INVA icon
1402
Innoviva
INVA
$1.57B
$829K ﹤0.01%
62,600
-26,650
-30% -$350K
ACCO icon
1403
Acco Brands
ACCO
$381M
$816K ﹤0.01%
146,000
-4,227
-3% -$22K
SBH icon
1404
Sally Beauty Holdings
SBH
$1.43B
$814K ﹤0.01%
65,000
-3,484
-5% -$42.8K
RWT
1405
Redwood Trust
RWT
$619M
$805K ﹤0.01%
119,100
IIPR icon
1406
Innovative Industrial Properties
IIPR
$1.78B
$797K ﹤0.01%
7,866
-4,934
-39% -$525K
UHAL.B icon
1407
U-Haul Holding Co Series N
UHAL.B
$12.5B
$771K ﹤0.01%
+14,025
New +$812K
NWSA icon
1408
News Corp Class A
NWSA
$14.8B
$765K ﹤0.01%
42,028
-444
-1% -$7.71K
PNR icon
1409
Pentair
PNR
$10.2B
$762K ﹤0.01%
16,941
GNR icon
1410
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.71B
$758K ﹤0.01%
13,291
-4,587
-26% -$258K
PRVB
1411
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$740K ﹤0.01%
70,000
SIVB
1412
DELISTED
SVB Financial Group
SIVB
$732K ﹤0.01%
3,179
+276
+10% +$68.6K
CBOE icon
1413
Cboe Global Markets
CBOE
$30.2B
$731K ﹤0.01%
5,824
-186
-3% -$23K
GTN icon
1414
Gray Television
GTN
$409M
$730K ﹤0.01%
65,200
-358,796
-85% -$4.45M
OPI
1415
DELISTED
Office Properties Income Trust
OPI
$728K ﹤0.01%
54,531
+272
+0.5% +$3.92K
GT icon
1416
Goodyear
GT
$2.04B
$711K ﹤0.01%
70,000
-3,819
-5% -$41.7K
NUS icon
1417
Nu Skin
NUS
$250M
$708K ﹤0.01%
16,800
-100
-0.6% -$3.85K
FCNCA icon
1418
First Citizens BancShares
FCNCA
$24.3B
$707K ﹤0.01%
932
+202
+28% +$163K
RYZ
1419
Ryerson Holding Corp
RYZ
$1.59B
$706K ﹤0.01%
23,337
-2,493
-10% -$73.9K
NTLA icon
1420
Intellia Therapeutics
NTLA
$1.49B
$698K ﹤0.01%
20,000
-479
-2% -$22.8K
BNL icon
1421
Broadstone Net Lease
BNL
$4.29B
$690K ﹤0.01%
42,559
-2,335
-5% -$39K
RGR icon
1422
Sturm, Ruger & Co
RGR
$620M
$675K ﹤0.01%
13,329
L icon
1423
Loews
L
$24.4B
$666K ﹤0.01%
11,420
+1,999
+21% +$111K
EBIX
1424
DELISTED
Ebix Inc
EBIX
$664K ﹤0.01%
33,273
ECHO
1425
EchoStar
ECHO
$25.1B
$661K ﹤0.01%
39,611
-1,933
-5% -$33.5K

Similar funds

Macquarie Group's Q4 2022 Portfolio in Review

As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.

  • Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
  • Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
  • Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
  • Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
  • Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
  • Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
  • Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.